Strengthening Antisense Oligonucleotide-Mediated Anti-Tumor Immunity via Metal–Organic Framework Nanoparticles
Year: 2026
Type: article
Abstract: ABSTRACT Overexpression of checkpoint proteins, such as programmed death ligand one (PD-L1), prevents immune recognition and enables cancer growth. Current monoclonal antibodies that block PD-L1 tend to be fragile, unable to penetrate tumors, and target cancer at later stages, thus leading to inconsistent patient outcomes. Antisense oligonucleotides (ASOs) provide an alternative to decrease PD-L1 expression, but require frequent high dosing due to fast degradation, rapid clearance, and poor cell uptake. To overcome these issues, we harnessed biocompatible metal-organic framework (MOF) nanoparticles, porous nanomaterials comprising metal nodes and organic linkers, to deliver ASOs. Encapsulating ASOs into MOFs enhances their stability and protection during intracellular delivery, leading to reduced PD-L1 expression and downstream immune recognition. Herein, we synthesized three distinct PD-L1-specific ASOs and loaded them individually into zirconium-based nano-sized NU-1000 MOFs, averaging ∼80% encapsulation efficiency. Release of encapsulated ASOs was sustained up to 7 days ex cellulo . MOF encapsulation increased ASO potency and reduced PD-L1 expression ∼ 3-fold and 2-fold in triple negative breast cancer EMT6 and melanoma B16-F10 cells, respectively. We evaluated the impact of MOF-delivered ASOs on PD-L1-expressing immune cells, where we observed ca. 12-fold increases in dendritic cell co-stimulatory marker expression, and amplified T cell activation and proliferation compared to untreated cells (4-fold and 10-fold, respectively). Notably, these changes drove a 3-fold increase in tumor caspase-3 expression, a key mediator for apoptosis. This research highlights how MOFs can be harnessed to bypass ASO limitations without requiring sequence modifications, and offers a broadly applicable platform for improved oligonucleotide delivery for various genes of interest.
Source: Nano Letters
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funders: U.S. Department of Defense, American Cancer Society, Arnold and Mabel Beckman Foundation, V Foundation for Cancer Research, Melanoma Research Foundation, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Hartwell Foundation, Florida Department of Health, Northwestern University, Boston University, Moffitt Cancer Center, National Institutes of Health, U.S. Army, International Institute for Nanotechnology, Northwestern University, National Cancer Institute, National Institute of General Medical Sciences, National Science Foundation Graduate Research Fellowship Program
Awards: G1354459900, G1900735392, G1962036933, NATIONAL DEFENSE EDUCATION POLICY - STEM PATHWAYS ENHANCED BIOTECHNOLOGY HIGH SCHOOL OUTREACH PROGRAM, Synthetic Biology and Biotechnology (SB2) Predoctoral Training Program, Integrated Program in Cancer and Data Science, G6496822995, Moffitt Skin Cancer SPORE, Harnessing Nanoscale Presentation to Elucidate the Impact of Therapeutic Packaging on Innate Immunity, Moffitt Cancer Center Support Grant, Translational Research in Biomaterials
OpenAlex ID: W7130569264
